Growth Metrics

Vivos (RDGL) Share-based Compensation (2010 - 2025)

Vivos recorded quarterly Share-based Compensation of $22687.0 in Q4 2025, up 112.27% quarter-over-quarter from $10688.0 in Q3 2025, and up 16.16% year-over-year from $19530.0 in Q4 2024.

Vivos' Share-based Compensation history runs 12 years deep, the most recent figure standing at $22687.0 for Q4 2025.

  • In Q4 2025, Share-based Compensation rose 16.16% year-over-year to $22687.0; the TTM figure through Dec 2025 stood at $42750.0 (down 51.93% YoY), while the FY2025 annual figure was $42750.0, down 51.93% from the prior year.
  • Share-based Compensation came in at $22687.0 for Q4 2025 at Vivos, up from $10688.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $56163.0 in Q3 2024 to a low of $3750.0 in Q2 2024.
  • A 3-year average of $15172.8 and a median of $9482.0 in 2024 frame the typical range for Share-based Compensation.
  • On a YoY basis, Share-based Compensation climbed as much as 24.99% in 2025 and fell as far as 80.97% in 2025.
  • Vivos' Share-based Compensation stood at $4880.0 in 2022, then surged by 300.2% to $19530.0 in 2024, then climbed by 16.16% to $22687.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $22687.0, $10688.0, and $4687.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 317.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 87.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 94.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 83.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 45.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 43.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 35.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 12.90 Mn
10 Vivos - - -3,105.00 22,687.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 22,687.00
Dec 31, 2025 22,687.00
Sep 30, 2025 10,688.00
Sep 30, 2025 10,688.00
Jun 30, 2025 4,687.00
Jun 30, 2025 4,687.00
Mar 31, 2025 4,688.00
Mar 31, 2025 4,688.00
Dec 31, 2024 19,530.00
Dec 31, 2024 19,530.00
Sep 30, 2024 56,163.00
Sep 30, 2024 56,163.00
Jun 30, 2024 3,750.00
Jun 30, 2024 3,750.00
Mar 31, 2024 9,482.00
Mar 31, 2024 9,482.00
Mar 31, 2022 4,880.00
Mar 31, 2022 4,880.00
Mar 31, 2018 449.00
Mar 31, 2018 449.00
Dec 31, 2017 4,045.00
Dec 31, 2017 4,045.00
Sep 30, 2017 24,283.00
Sep 30, 2017 24,283.00
Jun 30, 2017 27,059.00
Jun 30, 2017 27,059.00
Mar 31, 2017 28,240.00
Mar 31, 2017 28,240.00
Sep 30, 2016 27,427.00
Sep 30, 2016 27,427.00
Jun 30, 2016 584,916.00
Jun 30, 2016 584,916.00
Mar 31, 2015 28,500.00
Mar 31, 2015 28,500.00
Dec 31, 2014 216,448.00
Dec 31, 2014 216,448.00
Sep 30, 2014 5,400.00
Sep 30, 2014 5,400.00
Mar 31, 2014 10,900.00
Mar 31, 2014 10,900.00
Dec 31, 2013 45,686.00
Dec 31, 2013 45,686.00
Sep 30, 2013 6,500.00
Sep 30, 2013 6,500.00
Jun 30, 2013 75,670.00
Jun 30, 2013 75,670.00
Mar 31, 2013 7,800.00
Mar 31, 2013 7,800.00
Dec 31, 2012 201,000.00
Dec 31, 2012 201,000.00
Sep 30, 2012 780,001.00
Sep 30, 2012 780,001.00
Jun 30, 2012 51,801.00
Jun 30, 2012 51,801.00
Mar 31, 2012 359,144.00
Mar 31, 2012 359,144.00
Dec 31, 2011 47,000.00
Dec 31, 2011 47,000.00
Mar 31, 2011 18,000.00
Mar 31, 2011 18,000.00
Dec 31, 2010 68,248.00
Dec 31, 2010 68,248.00
Sep 30, 2010 425,000.00
Sep 30, 2010 425,000.00